Asthma and obesity increase inflammatory markers in children

Harshita Shailesh1, Safa Noor1, Lena Hayati1

  • 1Department of Pediatric Medicine, Division of Pulmonology, Sidra Medicine, Doha, Qatar.

Frontiers in Allergy
|February 4, 2025
PubMed

Insights

Asthma and obesity independently increase inflammation in children. Their combined presence alters inflammatory profiles but does not synergistically worsen inflammation, suggesting a moderating effect of obesity.

Area of Science:

  • Pediatric immunology
  • Inflammation research
  • Obesity and respiratory health

Background:

  • Asthma and obesity are independently linked to inflammation.
  • The combined impact of pediatric asthma and obesity on inflammatory mechanisms requires further investigation.
  • Understanding these interactions is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the interaction effects of asthma and obesity on inflammatory markers in children.
  • To assess how co-occurring asthma and obesity influence circulating cytokine and adipokine levels.
  • To determine if obesity exacerbates inflammation in children with asthma.

Main Methods:

  • Plasma levels of key cytokines (IL-2, IL-5, IL-10, IL-13, IL-17A, IL-22, IL-33, IFN-γ, TNF-α) and leptin were measured using multiplex and singleplex assays.
  • The study included four groups of children: normal weight with asthma, overweight/obese with asthma, overweight/obese without asthma, and normal weight without asthma.
  • Multiple regression analysis was employed to evaluate independent and interaction effects of asthma and obesity on inflammatory markers.

Main Results:

  • Asthma was associated with increased pro-inflammatory cytokines (IL-2, IL-5, IL-13, IL-17A, IL-22, IL-33, TNF-α) and decreased IL-10 and leptin.
  • Overweight/obesity correlated with elevated IL-5, IL-17A, IL-22, IL-33, TNF-α, leptin, and reduced IL-10.
  • A significant interaction between obesity and asthma was observed for IL-5, IL-10, IL-17A, IL-33, TNF-α, and leptin, but without synergistic amplification of inflammation.

Conclusions:

  • Both asthma and obesity independently impact inflammatory profiles in children.
  • The concurrent presence of asthma and obesity modifies inflammation but does not lead to a synergistic increase.
  • These findings suggest a moderating role of obesity in pediatric asthma-related inflammation, challenging previous assumptions.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
371